FDA identifies Avanos Medical’s Cortrak* 2 EAS recall as Class I
Avanos Medical recalled Cortrak* 2 EAS following reports of injuries and patient deaths due to tube misplacements.

Avanos Medical recalled Cortrak* 2 EAS following reports of injuries and patient deaths due to tube misplacements.
The deal adds Intersect ENT's PROPEL and SINUVA sinus implant product lines and technology to Medtronic's portfolio.
Xpert Xpress CoV-2 plus is a rapid molecular diagnostic test designed to identify Covid-19 causing virus.
The company’s net income in the quarter jumped 51.7% Y-o-Y to $454m.
In the same quarter a year ago, the company reported revenues of $375.3m.
The company reported revenues of $11.82bn for the first quarter of 2022.
The company also reorganised its operations into two reportable segments during the quarter.
Philips’ loss from continuing operations widened to €152m in the quarter.